Status | Study |
Recruiting |
Study Name: Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Patients With Hyperlipoproteinemia(a) and Cardiovascular Disease Condition: Elevated Lipoprotein(a) Cardiovascular Disease Date: 2017-01-31 Interventions: Drug: ISIS 681257 Randomly ass |
Completed |
Study Name: Plasma Triglyceride Lipolysis in Multifactorial Chylomicronemia Condition: Hyperlipoproteinemia Date: 2016-10-12 |
Recruiting |
Study Name: Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes Condition: Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia Date: 2016-05-26 |
Recruiting |
Study Name: Orlistat for the Treatment of Type I Hyperlipoproteinemia Condition: Hyperlipoproteinemia Type I Hypertriglyceridemia Date: 2016-05-02 Interventions: Drug: Orlistat Orlistat is a gastric and pancreatic lipase inhibitor that is approved by the FDA for wei |
Recruiting |
Study Name: The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome Condition: Familial Chylomicronemia Syndrome Lipoprotein Lipase Deficiency Date: 2016-01-12 Interventions: Drug: Volanesorsen 300 mg volanesorsen Other Names: |
Completed |
Study Name: Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia Condition: Hypercholesterolemia Hyperlipoproteinemia Type II Date: 2014-03-27 Interventions: Drug: AEM-28 Solution for inje |
Withdrawn |
Study Name: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction Condition: Mixed Hyperlipoproteinemia Date: 2014-02-20 Interventions: Dietary Supplement: Pro-Omega LDL Other: P |
Completed |
Study Name: The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia Condition: Hyperlipoproteinemia Date: 2013-08-16 Interventions: Drug: Coenzyme A Coenzyme A 40 |
Completed |
Study Name: Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia Condition: Hyperlipoproteinemia Date: 2013-06-10 Interventions: Drug: Coenzyme A Coenzyme A 40 |
Terminated |
Study Name: Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042) Condition: Hyperlipoproteinemia Type II Homozygous Familial Hypercholester Date: 2013-04-24 Interventions: Drug: Anacetrapib 100 mg table |